This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.

Here is a sample of this item:

by Stockwatch Business Reporter

The TSX Venture Exchange fell a fraction to 602.15 Friday, ending the week down 22.35 points. Stuart Olley's first capital pool shell, Cassowary Capital Corp. Ltd. (BIRD: halted), plans to acquire Lobo Genetics Inc. for the shell's qualifying transaction. The terms are not yet available, but Cassowary will roll back its 14 million shares, and Lobo will be raising money before year-end. According to documents filed with the B.C. Securities Commission, Lobo sold $4.94-million worth of shares at 50 cents in June and July.

Lobo is a Toronto company with a portable DNA testing device called the Cube. The company is not yet selling the device, but the Cube is ready and available for demonstrations. Each side of the Cube measures four inches. The Cube can perform a DNA test in less than an hour on a sample collected by cheek swab. Lobo hopes to sell the Cube to marijuana retailers, dispensaries, pharmacies and medical clinics, but the product has not yet received Health Canada approval as a medical device. Therefore, Lobo has a disclaimer that the Cube is only for "research and informational use" at the moment.

The remainder is available to Stockwatch subscribers.
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS